Anika Therapeutics (ANIK) Income Statement

Click line-items for a historical chart and %

Product revenue	25.78M
Licensing, milestone and contract revenue	6K
Total revenue	25.79M
Operating expenses:
Cost of product revenue	5M
Research & development	2.82M
Selling, general & administrative	4.28M
Total operating expenses	12.1M
Income from operations	13.69M
Interest income (expense), net	93K
Income before income taxes
Provision for income taxes	4.83M
Net income	8.95M
Basic net income per share:
Net income	0.61
Basic weighted average common shares outstanding	14.63M
Diluted net income per share:
Net income	0.59
Diluted weighted average common shares outstanding	15.08M
Net income	8.95M
Other comprehensive income (loss)
Foreign currency translation adjustment
Comprehensive income (loss)	9.26M

Entities mentioned with ANIK